Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Bryant

Showing results (581-590 of 622) with videos related to

Pageof 63
Sort By:
Journal of Leukocyte Biology|December 18, 2013
Simple diagnosis of STAT1 gain-of-function alleles in patients with chronic mucocutaneous candidiasisYoko Mizoguchi, Miyuki Tsumura, Satoshi Okada, et al.
American Journal of Human Genetics|August 18, 2015
Haploinsufficiency of the NF-κB1 Subunit p50 in Common Variable ImmunodeficiencyManfred Fliegauf, Vanessa L Bryant, Natalie Frede, et al.
Biorxiv : the Preprint Server for Biology|April 10, 2026
Atlas of HIV cis-regulatory elements reveals extensive transcriptional variation across clades, isolates, and within individualsBerkay Engin, Mohamed Y ElSadec, Joseph A Finkelberg, et al.
Science Translational Medicine|October 23, 2024
Stromal reprogramming overcomes resistance to RAS-MAPK inhibition to improve pancreas cancer responses to cytotoxic and immune therapyXiuting Liu, John M Baer, Meredith L Stone, et al.
Cancer Cell|January 4, 2016
Long-Term ERK Inhibition in KRAS-Mutant Pancreatic Cancer Is Associated with MYC Degradation and Senescence-like Growth SuppressionTikvah K Hayes, Nicole F Neel, Chaoxin Hu, et al.
Journal of Dental Research|July 22, 2016
A Cluster-Randomized, Community-Based, Tribally Delivered Oral Health Promotion Trial in Navajo Head Start ChildrenP A Braun, D O Quissell, W G Henderson, et al.
Cancer Cell|November 14, 2018
KRAS Suppression-Induced Degradation of MYC Is Antagonized by a MEK5-ERK5 Compensatory MechanismAngelina V Vaseva, Devon R Blake, Thomas S K Gilbert, et al.
Cancer Research|April 29, 2026
KRAS Signaling Inhibition Induces a Targetable Metabolic Dependency on Lipophagy-Dependent Fatty Acid Oxidation in Pancreatic CancerRavi Thakur, Dezhen Wang, Tuo Hu, et al.
Human Molecular Genetics|November 20, 2012
Haploinsufficiency at the human IFNGR2 locus contributes to mycobacterial diseaseXiao-Fei Kong, Guillaume Vogt, Yuval Itan, et al.
Cancer Research|November 8, 2022
Combination Therapies with CDK4/6 Inhibitors to Treat KRAS-Mutant Pancreatic CancerCraig M Goodwin, Andrew M Waters, Jennifer E Klomp, et al.
Pageof 63

Showing results (581-590 of 622) with videos related to

Sort By:
Pageof 63
Journal of Leukocyte Biology|December 18, 2013
Simple diagnosis of STAT1 gain-of-function alleles in patients with chronic mucocutaneous candidiasisYoko Mizoguchi, Miyuki Tsumura, Satoshi Okada, et al.
American Journal of Human Genetics|August 18, 2015
Haploinsufficiency of the NF-κB1 Subunit p50 in Common Variable ImmunodeficiencyManfred Fliegauf, Vanessa L Bryant, Natalie Frede, et al.
Biorxiv : the Preprint Server for Biology|April 10, 2026
Atlas of HIV cis-regulatory elements reveals extensive transcriptional variation across clades, isolates, and within individualsBerkay Engin, Mohamed Y ElSadec, Joseph A Finkelberg, et al.
Science Translational Medicine|October 23, 2024
Stromal reprogramming overcomes resistance to RAS-MAPK inhibition to improve pancreas cancer responses to cytotoxic and immune therapyXiuting Liu, John M Baer, Meredith L Stone, et al.
Cancer Cell|January 4, 2016
Long-Term ERK Inhibition in KRAS-Mutant Pancreatic Cancer Is Associated with MYC Degradation and Senescence-like Growth SuppressionTikvah K Hayes, Nicole F Neel, Chaoxin Hu, et al.
Journal of Dental Research|July 22, 2016
A Cluster-Randomized, Community-Based, Tribally Delivered Oral Health Promotion Trial in Navajo Head Start ChildrenP A Braun, D O Quissell, W G Henderson, et al.
Cancer Cell|November 14, 2018
KRAS Suppression-Induced Degradation of MYC Is Antagonized by a MEK5-ERK5 Compensatory MechanismAngelina V Vaseva, Devon R Blake, Thomas S K Gilbert, et al.
Cancer Research|April 29, 2026
KRAS Signaling Inhibition Induces a Targetable Metabolic Dependency on Lipophagy-Dependent Fatty Acid Oxidation in Pancreatic CancerRavi Thakur, Dezhen Wang, Tuo Hu, et al.
Human Molecular Genetics|November 20, 2012
Haploinsufficiency at the human IFNGR2 locus contributes to mycobacterial diseaseXiao-Fei Kong, Guillaume Vogt, Yuval Itan, et al.
Cancer Research|November 8, 2022
Combination Therapies with CDK4/6 Inhibitors to Treat KRAS-Mutant Pancreatic CancerCraig M Goodwin, Andrew M Waters, Jennifer E Klomp, et al.
Pageof 63